Literature DB >> 25179685

Hematopoiesis in the equine fetal liver suggests immune preparedness.

J M Battista1, R L Tallmadge, T Stokol, M J B Felippe.   

Abstract

We investigated how the equine fetus prepares its pre-immune humoral repertoire for an imminent exposure to pathogens in the neonatal period, particularly how the primary hematopoietic organs are equipped to support B cell hematopoiesis and immunoglobulin (Ig) diversity. We demonstrated that the liver and the bone marrow at approximately 100 days of gestation (DG) are active sites of hematopoiesis based on the expression of signature messenger RNA (mRNA) (c-KIT, CD34, IL7R, CXCL12, IRF8, PU.1, PAX5, NOTCH1, GATA1, CEBPA) and protein markers (CD34, CD19, IgM, CD3, CD4, CD5, CD8, CD11b, CD172A) of hematopoietic development and leukocyte differentiation molecules, respectively. To verify Ig diversity achieved during the production of B cells, V(D)J segments were sequenced in primary lymphoid organs of the equine fetus and adult horse, revealing that similar heavy chain VDJ segments and CDR3 lengths were most frequently used independent of life stage. In contrast, different lambda light chain segments were predominant in equine fetal compared to adult stage, and surprisingly, the fetus had less restricted use of variable gene segments to construct the lambda chain. Fetal Igs also contained elements of sequence diversity, albeit to a smaller degree than that of the adult horse. Our data suggest that the B cells produced in the liver and bone marrow of the equine fetus generate a wide repertoire of pre-immune Igs for protection, and the more diverse use of different lambda variable gene segments in fetal life may provide the neonate an opportunity to respond to a wider range of antigens at birth.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25179685      PMCID: PMC4198492          DOI: 10.1007/s00251-014-0799-9

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  75 in total

1.  Antibody repertoire development in fetal and neonatal piglets. II. Characterization of heavy chain complementarity-determining region 3 diversity in the developing fetus.

Authors:  J E Butler; P Weber; M Sinkora; J Sun; S J Ford; R K Christenson
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

2.  Activation of macrophage CD8: pharmacological studies of TNF and IL-1 beta production.

Authors:  T J Lin; N Hirji; G R Stenton; M Gilchrist; B J Grill; A D Schreiber; A D Befus
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

4.  The V lambda J lambda repertoire in human fetal spleen: evidence for positive selection and extensive receptor editing.

Authors:  J Lee; N L Monson; P E Lipsky
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

5.  Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities.

Authors:  J L Xu; M M Davis
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

6.  Antibody repertoire development in fetal and neonatal piglets. XIV. Highly restricted IGKV gene usage parallels the pattern seen with IGLV and IGHV.

Authors:  J E Butler; Nancy Wertz; Xiuzhu Sun
Journal:  Mol Immunol       Date:  2013-04-23       Impact factor: 4.407

Review 7.  Origins and functions of B-1 cells with notes on the role of CD5.

Authors:  Robert Berland; Henry H Wortis
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

8.  Characterization of peripheral blood and pulmonary leukocyte function in healthy foals.

Authors:  M J Flaminio; B R Rush; E G Davis; K Hennessy; W Shuman; M J Wilkerson
Journal:  Vet Immunol Immunopathol       Date:  2000-03-15       Impact factor: 2.046

9.  Diversity of immunoglobulin lambda light chain gene usage over developmental stages in the horse.

Authors:  Rebecca L Tallmadge; Chia T Tseng; M Julia B Felippe
Journal:  Dev Comp Immunol       Date:  2014-04-12       Impact factor: 3.636

10.  Developmental progression of equine immunoglobulin heavy chain variable region diversity.

Authors:  Rebecca L Tallmadge; Chia T Tseng; Rebecca A King; M Julia B Felippe
Journal:  Dev Comp Immunol       Date:  2013-04-06       Impact factor: 3.636

View more
  6 in total

1.  Developmental expression of B cell molecules in equine lymphoid tissues.

Authors:  J M B Prieto; R L Tallmadge; M J B Felippe
Journal:  Vet Immunol Immunopathol       Date:  2016-12-13       Impact factor: 2.046

2.  Effects of autologous stromal cells and cytokines on differentiation of equine bone marrow-derived progenitor cells.

Authors:  Ute E Schwab; Rebecca L Tallmadge; Mary Beth Matychak; M Julia B Felippe
Journal:  Am J Vet Res       Date:  2017-10       Impact factor: 1.156

3.  Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.

Authors:  Rebecca L Tallmadge; Steven C Miller; Stephen A Parry; Maria Julia B Felippe
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

4.  Effect of a Histone Demethylase Inhibitor on Equine Herpesvirus-1 Activity In Vitro.

Authors:  Rebecca L Tallmadge; Emilija Žygelytė; Gerlinde R Van de Walle; Thomas M Kristie; M Julia B Felippe
Journal:  Front Vet Sci       Date:  2018-03-12

5.  Immunomodulatory Effects of the Meretrix Meretrix Oligopeptide (QLNWD) on Immune-Deficient Mice.

Authors:  Wen Zhang; Lei Ye; Fenglei Wang; Jiawen Zheng; Xiaoxiao Tian; Yan Chen; Guofang Ding; Zuisu Yang
Journal:  Molecules       Date:  2019-12-05       Impact factor: 4.411

6.  Novel Engraftment and T Cell Differentiation of Human Hematopoietic Cells in ART -/- IL2RG -/Y SCID Pigs.

Authors:  Adeline N Boettcher; Yunsheng Li; Amanda P Ahrens; Matti Kiupel; Kristen A Byrne; Crystal L Loving; A Giselle Cino-Ozuna; Jayne E Wiarda; Malavika Adur; Blythe Schultz; Jack J Swanson; Elizabeth M Snella; Chak-Sum Sam Ho; Sara E Charley; Zoe E Kiefer; Joan E Cunnick; Ellie J Putz; Giuseppe Dell'Anna; Jackie Jens; Swanand Sathe; Frederick Goldman; Erik R Westin; Jack C M Dekkers; Jason W Ross; Christopher K Tuggle
Journal:  Front Immunol       Date:  2020-02-06       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.